Company Filing History:
3 out of 109 
2 out of 505 
Years Active: 2011-2019
Title: **Ronen Ben-David: Innovator in Pharmaceutical Chemistry**
Introduction
Ronen Ben-David, based in Netanya, Israel, is a notable inventor with a strong focus on pharmaceutical innovations. With five patents to his name, he has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel solid-state compounds.
Latest Patents
Among his latest innovations are his patents related to solid-state forms of spiro-oxindole compounds. These inventions provide detailed methodologies and pharmaceutical compositions involving spiro-oxindole compounds such as funapide and its racemic mixture. His contributions ensure that these compounds are available in solid-state forms that enhance their therapeutic potential and usability in pharmaceutical applications.
Career Highlights
Ronen Ben-David has worked with prominent organizations in the pharmaceutical industry, including Xenon Pharmaceuticals Inc. and Teva Pharmaceutical Industries Limited. His career in these established companies has allowed him to focus on developing impactful pharmaceutical solutions.
Collaborations
Throughout his career, Ronen has collaborated with notable professionals in the field, including Anton Frenkel and Stephen Bierlmaier. These partnerships have fostered creative and innovative approaches to pharmaceutical challenges, leveraging their combined expertise to advance their projects.
Conclusion
Ronen Ben-David exemplifies the spirit of innovation in the pharmaceutical sector. With his extensive work on spiro-oxindole compounds and solid-state forms, he continues to play a crucial role in the advancement of pharmaceutical sciences, propelling the industry toward more effective treatment options. His ongoing contributions and collaborations ensure that he remains a key figure in the landscape of pharmaceutical inventions.